Pacific Capital Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-666
Closed -$207K 75
2025
Q1
$207K Sell
666
-25
-4% -$7.38K 0.04% 80
2024
Q4
$180K Sell
691
-76
-10% -$22.5K 0.03% 83
2024
Q3
$247K Sell
767
-23
-3% -$7.52K 0.04% 69
2024
Q2
$247K Buy
790
+96
+14% +$28.2K 0.05% 62
2024
Q1
$197K Buy
694
+7
+1% +$2.05K 0.05% 64
2023
Q4
$198K Buy
+687
New +$187K 0.05% 62
2020
Q4
Sell
-24
Closed -$6K 72
2020
Q3
$6K Buy
+24
New +$5.95K ﹤0.01% 181

Other funds holding AMGN

Pacific Capital Wealth Advisors's AMGN Position: Q2 2025 in Review

Pacific Capital Wealth Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 666 shares — an estimated $207K sold.

Pacific Capital Wealth Advisors first reported a position in AMGN in Q3 2020 and held it in 7 quarters. The position peaked at $247K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Pacific Capital Wealth Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Pacific Capital Wealth Advisors sold 666 Amgen shares in Q2 2025, an estimated $207K.
  • Pacific Capital Wealth Advisors first reported a position in Amgen in Q3 2020 and held it in 7 quarters.
  • Pacific Capital Wealth Advisors's Amgen position peaked at $247K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Pacific Capital Wealth Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.